611
Participants
Start Date
September 30, 2004
Primary Completion Date
April 30, 2006
Study Completion Date
April 30, 2006
Micafungin
IV
Caspofungin
IV
Chennai
Brussels
Brussels
Vienna
Brussels
Brussels
Liège
Ghent
Sankt Gallen
Aalst
Zagreb
New York
New York
Berlin
The Bronx
Valhalla
Manhasset
New Hyde Park
Stony Brook
Albany
Prague
Rochester
Pittsburgh
Allentown
Philadelphia
Philadelphia
West Reading
Washington D.C.
Baltimore
Baltimore
Fairfax
Charlottesville
Winston-Salem
Durham
Madrid
Madrid
Madrid
Madrid
Atlanta
Hanover
Augusta
Augusta
Miami
Bielefeld
Bay Pines
Birmingham
Salamanca
Memphis
Jackson
Santander
Jackson
Lexington
Seville
Columbus
Cincinnati
Valencia
Beech Grove
Evansville
Detroit
Detroit
Barakaldo
Des Moines
Cologne
Iowa City
Minneapolis
Bangalore
Metz
Maywood
Frankfurt
Chicago
Chicago
St Louis
Kansas City
Strasbourg
Wichita
New Orleans
Little Rock
Paris
Dallas
Paris
Paris
Paris
Houston
San Antonio
Denver
Denver
Ulm
Los Angeles
Los Angeles
Bobigny
Villejuif
San Francisco
Villejuif
Würzburg
Seattle
Bangalore
Boston
Boston
Boston
Neptune City
Providence
Belo Horizonte
Belo Horizonte
Belo Horizonte
Cunitiba
Rio de Janeiro
Porto Alegre
Bangalore
Chandigarh
Kochi
Santos
São José do Rio Preto
São Paulo
Belo Horizonte
Belo Horizonte
Belo Horizonte
Salvador
Salvador
São Paulo
São Paulo
São Paulo
Edmonton
Kelowna
Winnipeg
St. John's
Halifax
Hamilton
Kingston
Ottawa
Toronto
Chicoutimi
Greenfield Park
Montreal
Montreal
Québec
Regina
Saskatoon
Banglore
Chennai
Cochin Kerala
Hyderabad
Hyderabad
Hyderabad
Hyderabad
Kolkotta
Lucknow
Ludhiana
Mangalore
Manipal
Mumbai
Mumbai
Uttar Pradesh
Groningen
Gdansk
Lodz
Warsaw
Barcelona
Barcelona
Barcelona
Barcelona
London
London
London
Manchester
Glasgow
Leeds
Leeds
Lead Sponsor
Astellas Pharma Inc
INDUSTRY